Use of Modified YOLOv5 Algorithm in the Differential Diagnosis of Colonic Crohn's Disease and Ulcerative Colitis on CTE Images
- PMID: 40740978
- PMCID: PMC12310326
- DOI: 10.1155/grp/1506567
Use of Modified YOLOv5 Algorithm in the Differential Diagnosis of Colonic Crohn's Disease and Ulcerative Colitis on CTE Images
Abstract
Background: Inflammatory bowel disease (IBD) is an immune-mediated disorder characterized by intestinal inflammation and includes two subtypes: Crohn's disease (CD) and ulcerative colitis (UC). The computed tomography manifestations of colonic CD (cCD) and UC are similar, and differential diagnosis is challenging. Our study aimed to investigate the feasibility of using a modified YOLOv5 algorithm for differentiating between cCD and UC on computed tomography enterography (CTE) images. Methods: This multicenter retrospective study analyzed data from a total of 29 cCD patients and 29 UC patients. Five submodels (YOLOv5n, YOLOv5s, YOLOv5m, YOLOv5l, and YOLOv5x) of YOLOv5 were trained and evaluated on the datasets. The CTE images of the cCD group and UC group were divided into a training set, validation set, and test set at a ratio of 8:1:1. Finally, the precision (Pr), recall rate (Rc), and mean average precision (mAP_0.5 and mAP_0.5:0.95) of the models were compared. Results: The YOLOv5x model showed the best performance among the five submodels, with mAP_0.5 of 0.97 and mAP_0.5:0.95 of 0.97 and 0.84 in the validation set and mAP_0.5 and mAP_0.5:0.95 of 0.97 and 0.83 in the test set, respectively. These results demonstrated similar diagnostic accuracy to the two radiologists (84.5%). Conclusion: The modified YOLOv5 algorithm is a feasible approach to distinguish between cCD and UC on CTE images. These findings may facilitate the early detection and differential diagnosis of IBD.
Keywords: artificial intelligence; diagnosis; inflammatory bowel disease; machine learning.
Copyright © 2025 Mingbo Bao et al. Gastroenterology Research and Practice published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures







Similar articles
-
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2. Cochrane Database Syst Rev. 2021. PMID: 34844288 Free PMC article.
-
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study.Therap Adv Gastroenterol. 2025 Jul 17;18:17562848251352023. doi: 10.1177/17562848251352023. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40718705 Free PMC article.
-
Machine Learning Models Based on CT Enterography for Differentiating Between Ulcerative Colitis and Colonic Crohn's Disease Using Intestinal Wall, Mesenteric Fat, and Visceral Fat Features.Acad Radiol. 2025 Jun 23:S1076-6332(25)00553-7. doi: 10.1016/j.acra.2025.06.005. Online ahead of print. Acad Radiol. 2025. PMID: 40555639
-
Artificial intelligence in inflammatory bowel disease endoscopy - a review of current evidence and a critical perspective on future challenges.Therap Adv Gastroenterol. 2025 Jul 13;18:17562848251350896. doi: 10.1177/17562848251350896. eCollection 2025. Therap Adv Gastroenterol. 2025. PMID: 40661220 Free PMC article. Review.
-
Ischemic Stroke May Increase the Risk of Crohn's Disease and Ulcerative Colitis: Evidence from a Bidirectional Mendelian Randomization Study.World Neurosurg. 2025 Apr;196:123718. doi: 10.1016/j.wneu.2025.123718. Epub 2025 Mar 13. World Neurosurg. 2025. PMID: 39929265
References
-
- Alatab S., Sepanlou S. G., Ikuta K., et al. The Global, Regional, and National Burden of Inflammatory Bowel Disease in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterology and Hepatology . 2020;5(1):17–30. doi: 10.1016/S2468-1253(19)30333-4. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials